Emulate
Company

Last deal

$47.1M

Amount

Series F

Stage

20.03.2024

Date

10

all rounds

$271.3M

Total amount

General

About Company
Emulate creates in vitro models to study the impact of diseases, medicines, chemicals, and foods on human health.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Emulate Living MicroDevices

founded date

01.01.2013

Number of employees

Company Type

For Profit

Last funding type

Series F

IPO status

Private

Description

The company's lab-ready Human Emulation System® consists of three components: the Zoë® Culture Module, Organ-Chips, and analytical software applications. Their platform integrates micro-engineering with living human cells to emulate human biology and provide detailed insights into how different factors affect human health. Research conducted using their Organ-Chips has been published in high-impact scientific journals and their technology has been recognized with awards and acquisitions by prestigious institutions.
Contacts

Phone number

Social url